Related information appears in other stories and tables in this issue Also see "Contamination Issues Drove Drug Recalls to Record Levels in 2011" - Pink Sheet, 28 March, 2012. ([A#08120328002]) ([A#08120328003]) ([A#08120328009]). Open, download and search a first-ever database from “The Gold Sheet” of last year’s drug recall information.
Drug Product Recalls In 2011: Categorized By Problem Area
This table lists every drug recall of 2011, along with a description of the drug product, the manufacturer, the recaller, the recall class and the reason for the recall.
More from Manufacturing
• By
While the pharma industry appears to be exempt from US tariffs imposed by President Trump, a member of the UK House of Lords says the details are unknown and warned that uncertainty “leads to less investment” in business as a whole.
• By
Trump announced a 26% reciprocal tariff on India, but a country-agnostic exemption of pharmaceuticals implies that the interests of Indian firms are protected for now. What is Indian pharma’s business exposure and what is domestic industry saying?
• By
Industry lobbing for pharmaceuticals to be exempt from President Trump’s sweeping US tariffs appears to have paid off.
• By
Pharma executives and investors are waiting with bated breath to find out if President Trump will include drugs in a new round of tariffs to be announced on 2 April.
More from Compliance
• By
Amid ongoing generic drug supply problems, Japan's government is to set up a new fund to support corporate investments geared towards manufacturing and consolidation.
• By
Pharma executives and investors are waiting with bated breath to find out if President Trump will include drugs in a new round of tariffs to be announced on 2 April.
• By
Results from a single-arm study cannot support representations on overall survival, progression-free survival and disease control rate for the cancer drug, the Office of Prescription Drug Promotion said in another “untitled” letter implicating the agency’s CFL guidance.